| 词条 | Anadis |
| 释义 |
Anadis is a biotechnology company based in Melbourne, Australia.[1] In 2008 Anadis changed its name to Immuron Ltd. The company focused on antigen-primed, dairy-derived health products. Immuron’s proprietary technology enables it to rapidly develop polyclonal antibody and other proteins-based solutions to a range of important diseases.{{Citation needed|date=March 2011}} Immuron specialises in nutraceutical, pharmaceutical and related therapeutic technology products, including Oral and GI Mucositis, Routine and Avian Influenza, - E. coli Travellers' diarrhoea (TD), Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD), and Anthrax containment. In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for distribution of Travelan, a product by Anadis, in Canadian market.[2] External links
References1. ^{{Cite web|url=http://www.asx.com.au/asx/markets/PriceResults.jsp?method=get&template=F1001&ASXCodes=IMC |title=Anadis |publisher=Australian Stock Exchange |date=2007-06-05 }}{{dead link|date=July 2017 |bot=InternetArchiveBot |fix-attempted=yes }} {{Biotech-stub}}{{pharmacy-stub}}2. ^{{Cite web|url=http://www.asiapacific.ca/news/valeo-pharma-baralex-sign-distribution-agreement-australias-|title=Valeo Pharma, Baralex Sign Distribution Agreement with Australia's Anadis Ltd.|last=Canada|first=Asia Pacific Foundation of|website=Asia Pacific Foundation of Canada|access-date=2017-09-18}} 2 : Pharmaceutical companies of Australia|Companies listed on the Australian Securities Exchange |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。